Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudia Arabia: The “BENEFIT-KSA” Study

Device

Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudia Arabia: The “BENEFIT-KSA” Study


Protocol number

PTL-1000518


License Number

Dexcom, Inc.


Status

Ongoing


Trial site

King Fahad Medical City, Riyadh